Tags: autologous stem cell transplantationb cell non hodgkin lymphomab-cellB-cell lymphomaBCLbloodblood cancercancerctxcytarabinehaematologyhematologyHSCTlenalidomidelymphomamaintenance therapymantle cellmantle cell lymphomamantle zonemulticentreNHLNon-Hodgkin Lymphomaoncologypfsphase 3phase 3 trialplateletprogression-free survivalR-CHOPr-hd cytarabinerandomisedremissionstem cellstem cell transplantstem cell transplantationsurvival outcomestransplanttransplantationtreatment-related death